Economic Modeling of the Cost of Chronic Lymphocytic Leukemia Therapy: It Is About the Model

J Clin Oncol. 2017 Jun 1;35(16):1863-1864. doi: 10.1200/JCO.2016.71.9690. Epub 2017 Mar 13.

Authors

Chadi Nabhan¹, Anthony R Mato¹

Affiliation

¹ Chadi Nabhan, Cardinal Health, Dublin, OH; and Anthony R. Mato, University of Pennsylvania, Philadelphia, PA.

PMID: 28549225
DOI: 10.1200/JCO.2016.71.9690

No abstract available

Publication types

Letter
Comment

MeSH terms

Cost of Illness
Cost-Benefit Analysis
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
United States